Business Wire

PUMA

1.9.2022 10:02:38 CEST | Business Wire | Press release

Share
Conference of the People, Powered by PUMA Puts Gen Z Voices Front and Centre

New research from PUMA, which surveyed 6,000 young people aged 18-25 from the UK, US, France, Germany, Italy and Spain has revealed that 94% of them care about the environment. At the same time, however, almost one in five aren’t motivated to help improve sustainability because the focus is always on older generations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220901005328/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Conference of the People, powered by PUMA, is a first of its kind event which will focus on the voices of Gen Z, as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. (Photo: Business Wire)

The sports company is addressing this focus with Conference of the People, powered by PUMA. The first of its kind event will centre the voices of Gen Z as the fashion industry comes together to discuss solutions towards more sustainable processes and practises. Live from London, streamed to the world on September 6th.

When asked what they would like to see brands doing more of when it comes to environment and sustainability, taking quicker action came out on top (52%). Making more commitments to change what they’re doing came next (49%), followed by communicating their goals better (40%) and being transparent with customers (34%). Two fifths of them are interested in connecting with brands to actively make the change themselves. It once again became clear that young people want brands to listen to their thoughts and opinions on the climate emergency as well. A quarter (26%) of those surveyed do not feel that there is a platform for their generation’s opinions regarding environmental sustainability. The same amount also said they want brands to create platforms to hear from younger generations.

For its one-day event, happening this month, PUMA has compiled panels that will feature some of the most prominent voices in sustainable fashion along with some famous faces that everyone will recognise, as well as next generation thinkers. Topics for discussion include tackling waste, using more sustainable materials, impacting climate change, and finding ways for the industry to collaborate to achieve results sooner.

Eco-anxiety is also on the rise amongst young people. Over a third (36%) of them admitted to feeling very anxious about global warming and the climate emergency. The number is highest in Italy (66%). The sportswear brand plans to tackle this head on. Actress, model, and activist Cara Delevingne will feature in a conversation on how young people can manage the anxieties they’re facing when it comes to the climate crisis.

Conference of the People, powered by PUMA is a first of its kind event. The aim is to create an environment for PUMA’s industry peers, activists, NGOs, experts, ambassadors, and consumers to come together and discuss solutions for some of the fashion industry’s most pressing sustainability challenges. All whilst amplifying the of voices of young people across the world.

Anne-Laure Descours, Chief Sourcing Officer at PUMA says, “With 71% of young people believing that their voices aren’t heard when it comes to environmental sustainability, it’s clear there’s a problem. Gen Z will have to live with climate decisions that are being made today, so we recognise that it’s important that they’re heard in these conversations. My hope is that through Conference of the People, we can give a platform to their voices and create a safe environment for them to collaborate with us, as an industry, on new and better ways of operating.”

To learn more about Conference of the People and to register interest in physical or virtual attendance, users can visit PUMACOP.com and follow @PUMA and [insert local IG if applicable] on social media.

Conference of the People will start on September 6 at 12pm BST (1pm CET, 7 am ET) and the livestream of the event is free to access for all.

PUMA

PUMA is one of the world’s leading sports brands, designing, developing, selling and marketing footwear, apparel and accessories. For more than 70 years, PUMA has relentlessly pushed sport and culture forward by creating fast products for the world’s fastest athletes. PUMA offers performance and sport-inspired lifestyle products in categories such as Football, Running and Training, Basketball, Golf, and Motorsports. It collaborates with renowned designers and brands to bring sport influences into street culture and fashion. The PUMA Group owns the brands PUMA, Cobra Golf and stichd. The company distributes its products in more than 120 countries, employs about 16,000 people worldwide, and is headquartered in Herzogenaurach/Germany.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005328/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye